Caplacizumab-yhdp, which is administered by injection, is used in combination with plasma exchange and immunosuppressive therapy to treat aTTP.

A plasma exchange can also cause temporary low blood pressure and, in rare cases, shock.

TTP is a serious condition that requires urgent treatment including plasmapheresis (plasma exchange).

TTP is a serious condition that can be fatal and requires urgent treatment including plasmapheresis (plasma exchange).

The impact of motivational interviewing on self-perceived burden in patients receiving therapeutic plasma exchange

T1 - The impact of motivational interviewing on self-perceived burden in patients receiving therapeutic plasma exchange

The impact of motivational interviewing on self-perceived burden in patients receiving therapeutic plasma exchange.

Doctors may consider treatment with plasma exchange or immunoglobulin (IVIG) for acutely and severely affected children.

A plasma exchange can help to alleviate symptoms of the conditions above by removing harmful substances from the blood.

Cablivi should be administered upon initiation of plasma exchange therapy, based on a diagnosis of aTTP.

Removal of poisons from the body (activated carbon, droppers with electrolyte solutions), hemosorption, plasmapheresis (purification of the blood from toxic substances).

We considered treatment trials of plasma exchange alone or combined with steroids or immunosuppressive drugs.

When steroid therapy fails and severe vision loss persists, a treatment called plasma exchange therapy might help some people recover their vision.

In instances in which steroid therapy has failed and severe vision loss persists, a treatment called plasma exchange therapy may help some people recover their vision.

In cases where steroid therapy fails to cure the condition and acute loss of vision continues, a treatment option known as Plasma exchange therapy may be used to help some patients recover their visual ability.